RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VERSUS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): FOUR-YEAR FINDINGS FROM CERTITUDE

被引：0
|
作者：
Saliba, F. [14 ]
Duvoux, C. [5 ]
Dharancy, S. [6 ]
Dumortier, J. [7 ]
Calmus, Y. [11 ]
Gugenheim, J. [10 ]
Kamar, N. [13 ]
Salame, E. [3 ]
Neau-Cransac, M. [2 ]
Vanlemmens, C. [1 ]
Durand, F. [4 ]
Pageaux, G. [9 ]
Hardwigsen, J. [8 ]
Kamar, D. [12 ]
Capela, D. [12 ]
Gharbi, H. [12 ]
Conti, F. [11 ]
机构：
[1] Hop Jean Minjoz, Besancon, France
[2] Hop Haut Leveque, Bordeaux, France
[3] Hop Trousseau, Chambray Les Tours, France
[4] Hop Beaujon, Clichy, France
[5] Hop Henri Mondor, AP HP, Creteil, France
[6] CHRU Lille, Lille, France
[7] Hop Edouard Herriot, Lyon, France
[8] Hop La Timone, Marseille, France
[9] Hop St Eloi, Montpellier, France
[10] Hop Archet 2, Nice, France
[11] Hop La Pitie Salpetriere, AP HP, Paris, France
[12] Novartis Pharma SAS, Rueil Malmaison, France
[13] Hop Rangueil, Toulouse, France
[14] Hop Paul Brousse, AP HP, Villejuif, France
来源：
TRANSPLANT INTERNATIONAL | 2020年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O82
引用
收藏
页码：26 / 26
页数：1
相关论文
共 13 条
  • [1] RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VERSUS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): TWO-YEAR FINDINGS FROM CERTITUDE
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Calmus, Y.
    Gugenheim, J.
    Kamar, N.
    Salame, E.
    Neau-Cransac, M.
    Vanlemmens, C.
    Durand, F.
    Pageaux, G.
    Hardwigsen, J.
    Dawson, M. Ktiouet
    Conti, F.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 15 - 16
  • [2] RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): THREE-YEAR FINDINGS FROM CERTITUDE
    Saliba, Faouzi
    Duvoux, Christophe
    Dharancy, Sebastien
    Dumortier, Jerome
    Calmus, Yvon
    Gugenheim, Jean
    Kamar, Nassim
    Salame, Ephrem
    Cransac, Martine Neau
    Vanlemmens, Claire
    Durand, Francois
    Pageaux, Georges Philippe
    Hardwigsen, Jean
    Tindel, Malka
    Masson, Cecile
    Gharbi, Hakam
    Conti, Filomena
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 220 - 220
  • [3] RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): THREE-YEAR FINDINGS FROM CERTITUDE
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Calmus, Y.
    Gugenheim, J.
    Kamar, N.
    Salame, E.
    Neau-Cransac, M.
    Vanlemmens, C.
    Durand, F.
    Pageaux, G.
    Hardwigsen, J.
    Tindel, M.
    Masson, C.
    Gharbi, H.
    Conti, F.
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 18 - 18
  • [4] Long-Term Outcomes After Liver Transplantation (tx) with Everolimus (EVR) and Mycophenolic Acid (MPA) in a Calcineurin Inhibitor-Free Regimen: The CERTITUDE Trial
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Calmus, Y.
    Di Giambattista, F.
    Conti, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 392 - 392
  • [5] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR REGIMEN VERSUS MYCOPHENOLIC ACID WITH STANDARD CALCINEURIN REGIMEN IN ASIAN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR RESULTS FROM THE SUBGROUP ANALYSIS OF TRANSFORM STUDY
    Watarai, Yoshihiko
    Amante, Angel Joaquin
    Casasola, Concesa
    Kim, Myoung Soo
    Chang, Shen-Shin
    Han, Duck Jong
    Ingsathit, Atiporn
    Kee, Terence
    Kenmochi, Takashi
    Khullar, Dinesh
    Ruangkanchanasetr, Prajej
    Shu, Kuo-Hsiung
    Wong, Hin Seng
    Gawai, Apurva
    Hernandez-Gutierrez, Maria Pilar
    Danguilan, Romina
    [J]. TRANSPLANTATION, 2020, 104 (09) : S613 - S613
  • [6] POST HOC SUBGROUP ANALYSIS FROM ZEUS: OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuethrich, R. P.
    Pressmar, K.
    Porstner, M.
    May, C.
    Paulus, E. -M.
    Muehlfeld, A.
    Wolters, H. H.
    Witzke, O.
    Stahl, R. O.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 8 - 8
  • [7] OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN: A POST HOC SUBGROUP ANALYSIS OF ZEUS
    Lehner, F.
    Budde, K.
    Wuethrich, R. P.
    Witzke, O.
    Zeier, M.
    Hauser, I. A.
    Wolters, H. H.
    Suwelack, B.
    Heller, K.
    Reinke, P.
    Arns, W.
    Stahl, R.
    Muehlfeld, A.
    Eisenberger, U.
    Baeumer, D.
    Porstner, M.
    Sommerer, C.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 24 - 24
  • [8] Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuthrich, R.
    Pressmar, K.
    Hauser, I.
    Porstner, M.
    May, C.
    Paulus, E.
    Muehlfeld, A.
    Suwelack, B.
    Wolters, H.
    Witzke, O.
    Stahl, R.
    Budde, K.
    [J]. TRANSPLANTATION, 2014, 98 : 613 - 613
  • [9] Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuthrich, R.
    Pressmar, K.
    Hauser, I.
    Porstner, M.
    May, C.
    Paulus, E.
    Muehlfeld, A.
    Suwelack, B.
    Wolters, H.
    Witzke, O.
    Stahl, R.
    Budde, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 613 - 613
  • [10] OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM CNI TO EVEROLIMUS-BASED REGIMEN: 5 YEAR DATA POST HOC ANALYSIS FROM THE ZEUS STUDY
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Budde, K.
    Wuethrich, R.
    Reinke, P.
    Muehlfeld, A.
    Eisenberger, U.
    Stahl, R.
    Heller, K.
    Suwelack, B.
    Wolters, H.
    Hauser, I.
    Porstner, M.
    Witzke, O.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 242 - 243
12